IDEXX Laboratories (IDXX) versus The Competition Financial Review

IDEXX Laboratories (NASDAQ: IDXX) is one of 25 public companies in the “Diagnostic substances” industry, but how does it compare to its rivals? We will compare IDEXX Laboratories to similar businesses based on the strength of its analyst recommendations, earnings, valuation, institutional ownership, profitability, risk and dividends.

Insider and Institutional Ownership

How to Become a New Pot Stock Millionaire

87.4% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 53.1% of shares of all “Diagnostic substances” companies are owned by institutional investors. 2.6% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 13.5% of shares of all “Diagnostic substances” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for IDEXX Laboratories and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories 1 0 5 0 2.67
IDEXX Laboratories Competitors 103 371 570 19 2.48

IDEXX Laboratories presently has a consensus price target of $190.67, indicating a potential downside of 0.58%. As a group, “Diagnostic substances” companies have a potential upside of 18.37%. Given IDEXX Laboratories’ rivals higher possible upside, analysts clearly believe IDEXX Laboratories has less favorable growth aspects than its rivals.

Earnings and Valuation

This table compares IDEXX Laboratories and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
IDEXX Laboratories $1.97 billion $263.14 million 58.47
IDEXX Laboratories Competitors $308.35 million $13.85 million -44.44

IDEXX Laboratories has higher revenue and earnings than its rivals. IDEXX Laboratories is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

IDEXX Laboratories has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, IDEXX Laboratories’ rivals have a beta of 1.44, suggesting that their average stock price is 44% more volatile than the S&P 500.


This table compares IDEXX Laboratories and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IDEXX Laboratories 13.36% -432.19% 17.19%
IDEXX Laboratories Competitors -885.83% -65.54% -25.27%


IDEXX Laboratories beats its rivals on 8 of the 13 factors compared.

About IDEXX Laboratories

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with's FREE daily email newsletter.

Leave a Reply